• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产儿视网膜病变中的持续性无血管视网膜

Persistent avascular retina in retinopathy of prematurity.

作者信息

Tan Ting Fang, Tay Su Ann, Agarwal-Sinha Swati, Tan Gavin Siew Wei, Wu Wei-Chi, Tsai Andrew S H

机构信息

Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore.

KK Women'S and Children'S Hospital, Singapore, Singapore.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2025 Apr 3. doi: 10.1007/s00417-025-06820-x.

DOI:10.1007/s00417-025-06820-x
PMID:40178600
Abstract

Persistent avascular retina (PAR) has been increasingly reported with the increased use of anti-vascular endothelial growth factor (VEGF) agents in treatment-requiring ROP. However, they have also been observed in ROP eyes that did not meet treatment requirement and spontaneously regressed. PAR is highlighted in the updated nomenclature under the International Classification of Retinopathy of Prematurity, 3rd edition (ICROP3) consensus statement, underscoring the increased emphasis in detecting PAR. PAR has been noted to persist beyond existing ROP screening guidelines, and were found to be associated with complications like retinal tear and detachment, especially in eyes with more posterior PAR. Thus, serial monitoring of retinal vascularization, facilitated by fluorescein angiography and wide-field imaging, for these associated complications have been encouraged. The current lack of consensus in the follow-up and management of PAR prompts further work in this area: understanding the natural course of retinal vascularization in both untreated and treated ROP, the modulation of anti-VEGF on retinal function, and the clinical significance of PAR-associated vascular patterns can help to guide management protocols for PAR in ROP eyes.

摘要

随着抗血管内皮生长因子(VEGF)药物在需要治疗的早产儿视网膜病变(ROP)中使用的增加,持续性无血管视网膜(PAR)的报道越来越多。然而,在不符合治疗要求且自行消退的ROP眼中也观察到了PAR。在《早产儿视网膜病变国际分类》第3版(ICROP3)共识声明的更新术语中强调了PAR,这突出了对检测PAR的日益重视。已经注意到PAR持续超过现有的ROP筛查指南,并且发现其与视网膜撕裂和脱离等并发症相关,特别是在PAR更靠后的眼中。因此,鼓励通过荧光素血管造影和广角成像对视网膜血管化进行连续监测,以发现这些相关并发症。目前在PAR的随访和管理方面缺乏共识,这促使在该领域开展进一步的工作:了解未经治疗和接受治疗的ROP中视网膜血管化的自然病程、抗VEGF对视网膜功能的调节以及PAR相关血管模式的临床意义,有助于指导ROP眼中PAR的管理方案。

相似文献

1
Persistent avascular retina in retinopathy of prematurity.早产儿视网膜病变中的持续性无血管视网膜
Graefes Arch Clin Exp Ophthalmol. 2025 Apr 3. doi: 10.1007/s00417-025-06820-x.
2
Oral fundus fluorescein angiogram detects reactivation post anti-VEGF in aggressive retinopathy of prematurity.口服眼底荧光血管造影检测早产儿侵袭性视网膜病变抗VEGF治疗后的再激活情况。
Eye (Lond). 2025 Jul 11. doi: 10.1038/s41433-025-03896-x.
3
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.用于治疗早产儿视网膜病变的抗血管内皮生长因子(VEGF)药物。
Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD009734. doi: 10.1002/14651858.CD009734.pub3.
4
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.用于治疗早产儿视网膜病变的抗血管内皮生长因子(VEGF)药物。
Cochrane Database Syst Rev. 2016;2:CD009734. doi: 10.1002/14651858.CD009734.pub2. Epub 2016 Feb 27.
5
New insights in diagnosis and treatment for Retinopathy of Prematurity.早产儿视网膜病变诊断与治疗的新见解。
Int Ophthalmol. 2016 Oct;36(5):751-60. doi: 10.1007/s10792-016-0177-8. Epub 2016 Jan 14.
6
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
7
Bilateral Anti-VEGF on Same-Day-Investigation on Safety in Retinopathy of Prematurity: A Multicenter Retrospective Study.早产儿视网膜病变同一天双侧抗血管内皮生长因子治疗安全性的多中心回顾性研究
Ophthalmol Retina. 2025 May;9(5):484-492. doi: 10.1016/j.oret.2024.11.004. Epub 2024 Nov 12.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
9
Low-Dose Bevacizumab 0.03 mg for Treatment of Type 1 Retinopathy of Prematurity.低剂量贝伐单抗0.03毫克用于治疗1型早产儿视网膜病变
Ophthalmol Retina. 2025 Aug;9(8):807-811. doi: 10.1016/j.oret.2025.02.009. Epub 2025 Feb 12.
10
Relationship Between Refractive Parameter and Serum Vascular Endothelial Growth Factor Concentration and Optical Coherence Tomographic Angiography in Myopia Children with Retinopathy of Prematurity.早产视网膜病变近视儿童的屈光参数与血清血管内皮生长因子浓度及光学相干断层扫描血管造影的关系
Curr Eye Res. 2025 Sep;50(9):956-964. doi: 10.1080/02713683.2025.2503202. Epub 2025 May 21.

本文引用的文献

1
Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II.比较雷珠单抗和康柏西普治疗二区 1 型阈值前早产儿视网膜病变。
BMC Pediatr. 2024 Aug 30;24(1):556. doi: 10.1186/s12887-024-05017-1.
2
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.玻璃体内阿柏西普与激光治疗早产儿视网膜病变:FIREFLEYE 下一步非随机对照试验的两年疗效和安全性结果。
JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383.
3
Global, regional and national burden of retinopathy of prematurity among childhood and adolescent: a spatiotemporal analysis based on the Global Burden of Disease Study 2019.
全球、区域和国家早产儿视网膜病变负担:基于 2019 年全球疾病负担研究的时空分析。
BMJ Paediatr Open. 2024 Jan 6;8(1):e002267. doi: 10.1136/bmjpo-2023-002267.
4
Macular Thickness Is Associated with Persistent Avascular Retina in Patients with a History of Untreated Retinopathy of Prematurity.黄斑厚度与未经治疗的早产儿视网膜病变病史患者的持续性无血管视网膜有关。
Ophthalmol Retina. 2024 Feb;8(2):202-204. doi: 10.1016/j.oret.2023.10.004. Epub 2023 Oct 12.
5
The Incidence and Timing of Treatment-Requiring Retinopathy of Prematurity in Nanopremature and Micropremature Infants in the United States: A National Multicenter Retrospective Cohort Study.美国纳米早产儿和微早产儿中需要治疗的早产儿视网膜病变的发生率和发病时间:一项全国性多中心回顾性队列研究。
Ophthalmol Retina. 2024 Mar;8(3):279-287. doi: 10.1016/j.oret.2023.10.003. Epub 2023 Oct 13.
6
Imaging Features Associated with Persistent Avascular Retina in Retinopathy of Prematurity.早产儿视网膜病变中与持续性无血管视网膜相关的影像学特征
Ophthalmology. 2024 Jan;131(1):122-124. doi: 10.1016/j.ophtha.2023.09.032. Epub 2023 Oct 5.
7
Persistent Vascular Anomalies in Retinopathy of Prematurity Children: Ultrawide-field Fluorescein Angiography Findings until School Age.早产儿视网膜病变患儿的持续性血管异常:直至学龄期的超广角荧光素血管造影结果
Ophthalmol Sci. 2023 Feb 7;3(3):100281. doi: 10.1016/j.xops.2023.100281. eCollection 2023 Sep.
8
Avascular Peripheral Retina in Infants.婴儿无血管性周边视网膜
Turk J Ophthalmol. 2023 Feb 24;53(1):44-57. doi: 10.4274/tjo.galenos.2022.76436.
9
Computed Analysis of Retinal Vascular Growth After Bevacizumab Treatment of Retinopathy of Prematurity Until Age 3 Years.贝伐单抗治疗早产儿视网膜病变至3岁后视网膜血管生长的计算机分析
Clin Ther. 2023 Jan;45(1):4-16. doi: 10.1016/j.clinthera.2022.12.003. Epub 2022 Dec 28.
10
New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.早产儿视网膜病变治疗的新视角:现有疗法和新兴的新型疗法。
Int J Mol Sci. 2022 Aug 1;23(15):8529. doi: 10.3390/ijms23158529.